Surgeon in Chief, UCSF Benioff Children's Hospital Professor & Chief, Division of Pediatric Surgery Vice-Chair, Department of Surgery Michael R. Harrison, MD, Endowed Chair in Fetal Surgery Director, Fetal Treatment Center Clinical Lead, Surgical Innovations
Hanmin Lee, M.D. is Associate Professor of Surgery, and Director of the Fetal Treatment Center at UCSF. He is the second director in the 25+ year history of the Fetal Treatment Center, replacing Dr. Michael Harrison who continues to add his creative energies as Director Emeritus. Dr. Lee was an undergraduate at Johns Hopkins University who completed both medical school and general surgery residency at New York University. He did two years of postdoctoral research training under the mentorship of Dr. Jay Vacanti at Harvard Medical School, and two years of pediatric surgery fellowship at Emory University Medical Center before being recruited to a tenure-track faculty position in the Department of Surgery at UCSF in 2000.
Dr. Lee and his surgery associates confine their surgical practice exclusively to children. The group has a special interest in fetal surgery, in repair of complex defects involving the chest, lung, abdomen, bowel, and bladder, and surgical care of children from birth through adolescence. Dr. Lee and his associates, The Bay Area Pediatric Surgeons, do consultations and provide surgical care at Moffitt/Long Hospitals UCSF, California Pacific Medical Center, and Kaiser Permanente, San Francisco. They see patients regularly in their office hours and provide multidisciplinary clinics for fetal anomalies in their fetal treatment center. Additionally, they see patients with complex congenital anomalies that have been corrected by surgery in their Long-term Infant-to-adult Followup and Evaluation clinic.
Dr. Lee's clinical interests include neonatal surgery, fetal surgery, minimally invasive surgery and biliary surgery. His basic science research interests include tissue engineering, proteomic assessment of fetal-maternal diseases, and integration of emerging technologies into clinical surgery.
He has published numerous clinical and basic science articles in these fields. He is well-recognized as a leader in fetal surgery and pediatric minimally invasive surgery , having given numerous national and international talk. Additionally, he is on the editorial board of the pediatric endoscopic journal and in teaching fetal surgery and advanced pediatric laparoscopic courses. He has been a principal investigator or co-investigator on a number of fetal surgery and minimally invasive surgical trials, and is currently a co-investigator on a number of clinical trials including fetal surgery for myelomeningocele and is leading a multi-instiutional effort to investigate the role of maternal steroid administration for fetuses with large congenital cystic adenomatoid malformations.
Dr. Lee, his wife Barbara and their children, live in San Francisco and enjoy the multitude of outdoor activities and restaurants available in the Bay Area.
Clifton MS, Harrison MR, Ball R, Lee H. Fetoscopic Transuterine Release of Posterior Urethral Valves: A New Technique. Fetal Diagn Ther. 2007 Nov 23;23(2):81-86
Crombleholme TM, Shera D, Lee H, Johnson M, D'Alton M, Porter F, Chyu J, Silver R, Abuhamad A, Saade G, Shields L, Kauffman D, Stone J, Albanese CT, Bahado-Singh R, Ball RH, Bilaniuk L, Coleman B, Farmer D, Feldstein V, Harrison MR, Hedrick H, Livingston J, Lorenz RP, Miller DA, Norton ME, Polzin WJ, Robinson JN, Rychik J, Sandberg PL, Seri I, Simon E, Simpson LL, Yedigarova L, Wilson RD, Young B. A prospective, randomized, multicenter trial of amnioreduction vs selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome. Am J Obstet Gynecol. 2007 Oct;197(4):396.e1-9.
Vu L, Tsao K, Lee H, Nobuhara K, Farmer D, Harrison M, Goldstein RB. Characteristics of congenital cystic adenomatoid malformations associated with nonimmune hydrops and outcome. J Pediatr Surg. 2007 Aug;42(8):1351-6.
Yang SH, Nobuhara KK, Keller RL, Ball RH, Goldstein RB, Feldstein VA, Callen PW, Filly RA, Farmer DL, Harrison MR, Lee H. Reliability of the lung-to-head ratio as a predictor of outcome in fetuses with isolated left congenital diaphragmatic hernia at gestation outside 24-26 weeks. Am J Obstet Gynecol. 2007 Jul;197(1):30.e1-7.
Clifton MS, Pelayo JC, Cortes RA, Grethel EJ, Wagner AJ, Lee H, Harrison MR, Farmer DL, Nobuhara KK. Surgical treatment of childhood recurrent pancreatitis. J Pediatr Surg. 2007 Jul;42(7):1203-7.
UCSF Surgical Innovations Program - October 23, 2015
Two (2) Department of Surgery research teams were awarded seed funding totaling $40,000 to accelerate their medical device innovations. The Roboimplant device, an expandable rod for orthopaedic surgery applications, took top honors, with the Sentinel Bandage, a non-invasive technology for wound monitoring, taking second place. The awards were given at the UCSF Surgical Innovations Program's inaugural Shark Tank competition on September 24th at UCSF Mission Bay.
Four teams of finalists pitched [...]
UCSF Surgical Innovations Program - September 22, 2015
KQED Science for Personalized Medicine reports on a multitude of new sensor technologies that are being used to monitor medical issues, which would otherwise be time-consuming for hospital staff to manage. Hanmin Lee, M.D., Professor and Chief of the Division of Pediatric Surgery at UCSF as well as Medical Director of Surgical Innovations was interviewed for the article, offering his insights about the huge potential of the nascent field.
"I firmly believe that the next 50 years are going to [...]
Surgeons at the UCSF Benioff Children's Hospital in San Francisco are using magnets to reshape the breastbones of children who suffer from Sunken Chest Syndrome. The technique is undergoing phase 3 clinical trials, but the doctors hope to prove that long term magnetic force is as effective and less painful than conventional surgery.
The Society of Clinical Trials has named UCSF's Management of Myelomeningocele Study (MOMS), a review of prenatal versus postnatal surgery for myelomengingocele (spina bifida), as its Trial of the Year. The study earned recognition as an important clinical trial that overcame difficulties and produced remarkable results.
UCSF Pediatric Surgery has published thier first interactive Patient Guide iBook for the iPad. This multimedia guidebook is a free educational resource for families who are faced with Congenital Diaphragmatic Hernia (CDH). More guidebooks are being planned as well as epub versions for other ebook readers.
The inspiration for this project is a direct result of the generous support of the CDH research and patient education grant provided by the Nayeli Faith Foundation.
Hanmin Lee, M.D. has been selected as one of the UCSF Medical Center's "Exceptional Physicians of 2012". Dr. Lee is Professor, Surgery, Pediatrics, Ob-Gyn and Reproductive Health Services, Chief of the Division of Pediatric Surgery, Director of the UCSF Fetal Treatment Center, and the Surgeon-in-Chief of UCSF Benioff Children's Hospital. This award is given annually to physicians who have distinguished themselves as role models and demonstrate the values of UCSF Medical Center, [...]
For years, surgeons have been seeking ways of operating on babies in the womb, reasoning that medical abnormalities are easier to address while the fetus is still developing. Now, for the first time, a large clinical trial has shown that fetal surgery can also benefit infants with non life-threatening conditions. The eight-year study reported in the New England Journal of Medicine, found that babies born with myelomeningocele, the most common form of spina bifida, a debilitating spinal [...]
UCSF announces the formation of the Institute for Fetal and
Neonatal Health symposium brings together clinicians and basic
scientists involved in different aspects of development and fetal
As the new Director of the Fetal Treatment Center, Dr. Hanmin Lee will continue the Center's and its co-founder Dr. Michael Harrison's pioneering spirit of multidisciplinary research and innovation to improve our understanding of fetal disease and further advance the treatment and management of infants and children. Dr. Harrison will continue as Director Emeritus of the Fetal Treatment Center.